Efficacy and Safety of RC28-E Versus Aflibercept

Clinical trial NCT05727397 · UNKNOWN

Trial details

NCT number: NCT05727397
Sponsor: RemeGen Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Wet Age-related Macular Degeneration

Start date: 2023-03-14
Primary completion: 2025-11-29
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.